Most Recent
The banks and executives facing criminal charges over alleged cartel conduct related to ANZ's $2.5 billion share placement in 2015 will fight to widen their cross-examination of key ACCC witnesses after new information was brought to light in late submissions by the regulator.
A key witness from JPMorgan previously contested claims by the ACCC that a key component of an alleged cartel arrangement between four major banks around a $2.5 billion institutional share placement by ANZ was actually an 'agreement,' as opposed to a series of independent decisions, a court has heard.
Two key witnesses from JPMorgan have been grilled by lawyers for three major investments banks named in a high-stakes criminal cartel case as the banks seek to cast doubt on how the ACCC gathered evidence during its almost two-year cartel investigation.
Johnson & Johnson did not adequately warn of the risks of its pelvic mesh implants and is liable to pay damages to thousands of Australian women who suffered severe injuries from the devices, a judge has ruled in a long awaited decision in a class action launched more than seven years ago.
A Federal Court judge has reversed a prior ruling expanding the class in a lawsuit against Johnson & Johnson unit Ethicon over allegedly defective pelvic mesh implants, saying he had "no confidence" new group members would have sufficient opportunity to opt out before judgment is delivered in a few weeks.
An impending judgment in the long-running class action against Johnson & Johnson unit Ethicon over allegedly defective pelvic mesh implants has sent the parties scrambling about opt out notices and the Federal Court considering reversing prior orders that expanded the group definition.
An investigation by the Australian Competition and Consumer Commission has come under fire by the banks and directors targeted in a criminal case over alleged cartel conduct that claim the regulator "contaminated" key evidence and improperly used material supplied by ASIC.
GlaxoSmithKline has defeated claims by the ACCC that revised packaging for its now-discontinued pain killer Osteo Gel misled consumers. The drug maker will face penalties for earlier violations it admitted to, but the court hinted the damages will be nowhere near the $6 million competitor Reckitt Benckiser faced in a similar case.
A four-day trial against online ticket reseller Viagogo kicked off Monday, with the ACCC describing how the site misled consumers by falsely claiming it was an official ticket vendor, hitting them with a booking fee of around 28 per cent along the way.
Medical device maker American Medical Systems, which is facing a class action over allegedly faulty pelvic mesh implants, has taken a page from the Ethicon pelvic mesh defence playbook, calling on the court to restrict the dates for group membership.